|
5Fluorouracil Clinical Trials
5 actively recruiting trials across 3 locations
Also known as: 5-FU, Fluorouracil Accord, Fluorouracil Tevo
Pipeline
Phase 1: 1Phase 2: 2Phase 3: 1Phase 1/2: 1
Top Sponsors
- Uppsala University1
- Rutgers, The State University of New Jersey1
- I-Mab Biopharma US Limited1
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
- Eli Lilly and Company1
Indications
- Cancer5
- Colorectal Cancer2
- Lung Cancer2
- Gastroesophageal Junction Carcinoma1
- Peritoneal Metastases1
Other2 trials
Birmingham, Alabama1 trial
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
University of Alabama at Birmingham
Phase 1
Goodyear, Arizona1 trial
Elizabeth, New Jersey1 trial
ATATcH Alternating Treatment Plans for Advanced Cancer
Trinitas Hospital and Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.